Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | PAM | P19021 | 2/20 | 0.53 |
| ▸ | CES2 | O00748 | 3/20 | 0.52 |
| ▸ | CES1 | P23141 | 3/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | PPARG | P37231 | 5/20 | 0.50 |
| ▸ | PPARD | Q03181 | 5/20 | 0.50 |
| ▸ | PPARA | Q07869 | 5/20 | 0.50 |
| ▸ | HDAC11 | Q96DB2 | 4/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TLR2 | O60603 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | FABP4 | P15090 | 2/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.50 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.50 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL50589 | 1.00 | DGKA (0.59) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL627978 | 1.00 | DGKA (0.59) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL119874 | 1.00 | DGKA (0.59) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL17222526 | 1.00 | DGKA (0.59) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL2235744 | 1.00 | DGKA (0.59) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL22126637 | 1.00 | DGKA (0.59) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL60795 | 1.00 | DGKA (0.59) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL1698285 | 1.00 | DGKA (0.59) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL4631670 | 1.00 | DGKA (0.59) | DGKALMNAPAMCES2CES1 | |
| SCHEMBL3219935 | 1.00 | DGKA (0.59) | DGKALMNAPAMCES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3061 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116710123-A | Cytokine release and inhibition of cytokine storm | 萨恩帕斯药物有限公司 | 2023-09-05 | — | — | CN | claimed |
| EP-4188398-A1 | SUPPRESSION OF CYTOKINE RELEASE AND CYTOKINE STORM | Signpath Pharma, Inc. (US) | 2023-06-07 | — | — | EP | claimed |
| EP-3151837-B1 | PROTECTIVE EFFECT OF DMPC, DMPG, DMPC/DMPG, EGPG, LYSOPG AND LYSOPC AGAINST DRUGS THAT CAUSE CHANNELOPATHIES | SIGNPATH PHARMA INC (US) | 2023-03-15 | — | — | EP | claimed |
| EP-3082768-B1 | LIPOSOMAL MITIGATION OF DRUG-INDUCED INHIBITION OF THE CARDIAC IKR CHANNEL | SIGNPATH PHARMA INC (US) | 2023-02-22 | — | — | EP | claimed |
| US-20220401558-A1 | NANOTUBE TRANS-MEMBRANE CHANNELS MIMICKING BIOLOGICAL PORINS | U.S. DEPARTMENT OF ENERGY | 2022-12-22 | — | — | US | claimed |
| US-11439708-B2 | Nanotube trans-membrane channels mimicking biological porins | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC (US) | 2022-09-13 | — | — | US | claimed |
| CN-114796030-A | Skin-refreshing essence and preparation method thereof | 安婕妤化妆品科技股份有限公司 | 2022-07-29 | — | — | CN | claimed |
| US-20220054389-A1 | BOTULINUM NANOEMULSIONS | UNIVERSITY OF MASSACHUSETTS LOWELL (US) | 2022-02-24 | — | — | US | claimed |
| WO-2022026170-A1 | SUPPRESSION OF CYTOKINE RELEASE AND CYTOKINE STORM | SIGNPATH PHARMA, INC. (US) | 2022-02-03 | — | — | WO | claimed |
| CN-113633614-A | Efficient antibacterial natural tea tree essential oil nanoemulsion preparation for treating intractable dental ulcer and preparation method and application thereof | 中国人民解放军陆军军医大学 | 2021-11-12 | — | — | CN | claimed |
| US-6726919-B2 | FOR INDUCING OR MAINTAINING ANESTHESIA OR SEDATION IN A PATIENT | RTP PHARMA, INC. | 2004-04-27 | — | — | US | claimed |
| WO-2002032396-A9 | LIPID-PROTEIN-SUGAR PARTICLES FOR DELIVERY OF NUCLEIC ACIDS | MASSACHUSETTS INST TECHNOLOGY (US) | 2003-07-17 | — | — | WO | claimed |
| EP-1292282-A2 | IMPROVED INJECTABLE DISPERSIONS OF PROPOFOL | RTP Pharma Inc. (CA) | 2003-03-19 | — | — | EP | claimed |
| US-20020150621-A1 | Lipid-protein-sugar particles for drug delivery | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2002-10-17 | — | — | US | claimed |
| US-20020150626-A1 | Lipid-protein-sugar particles for delivery of nucleic acids | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2002-10-17 | — | — | US | claimed |
| WO-2002032398-A2 | LIPID-PROTEIN-SUGAR PARTICLES FOR DRUG DELIVERY | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2002-04-25 | — | — | WO | claimed |
| WO-2002032396-A2 | LIPID-PROTEIN-SUGAR PARTICLES FOR DELIVERY OF NUCLEIC ACIDS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2002-04-25 | — | — | WO | claimed |
| US-20020022667-A1 | Injectable dispersions of propofol | ASTORA WOMEN'S HEALTH HOLDINGS, LLC | 2002-02-21 | — | — | US | claimed |
| WO-2001097779-A2 | IMPROVED INJECTABLE DISPERSIONS OF PROPOFOL | RTP PHARMA INC. (CA) | 2001-12-27 | — | — | WO | claimed |
| US-4058122-A | Osmotic system with laminated wall formed of different materials | ALZA CORPORATION (US) | 1977-11-15 | — | — | US | claimed |